The fidelity of synaptic transmission depends on the integrity of the protein machinery at the synapse. Unfolded synaptic proteins undergo refolding or degradation in order to maintain synaptic proteostasis and preserve synaptic function, and buildup of unfolded/toxic proteins leads to neuronal dysfunction. Many molecular chaperones contribute to proteostasis, but one in particular, cysteine string protein (CSPα), is critical for proteostasis at the synapse. In this study we report that exported vesicles from neurons contain CSPα. Extracellular vesicles (EV's) have been implicated in a wide range of functions. However, the functional significance of neural EV's remains to be established. Here we demonstrate that co-expression of CSPα with the disease-associated proteins, polyglutamine expanded protein 72Q huntingtin ex°n1 or superoxide dismutase-1 (SOD-1 G93A) leads to the cellular export of both 72Q huntingtin ex°n1 and SOD-1 G93A via EV's. In contrast, the inactive CSPα HPD-AAA mutant does not facilitate elimination of misfolded proteins. Furthermore, CSPα-mediated export of 72Q huntingtin ex°n1 is reduced by the polyphenol, resveratrol. Our results indicate that by assisting local lysosome/ proteasome processes, CSPα-mediated removal of toxic proteins via EVs plays a central role in synaptic proteostasis and CSPα thus represents a potential therapeutic target for neurodegenerative diseases.
Results
CSPα is secreted from neurons. CSPα is a well-established component of the presynaptic proteostasis network 7, 10, 40 . To begin to address whether CSPα's neuroprotective activity involves its export, we sought to establish if CSPα is released from neurons like DnaJB1 13 and DnaJB11 12 . To this end, myc-tagged CSPα was expressed in CAD cells, the culture media was replaced with fresh media 6 hrs after transfection and at 48 hrs, the medium was collected, centrifuged (1, 500Xg) to remove dead cells and the presence of exported CSPα determined. Figure 1 shows three exported species of CSPα, consistent with the unpalmitoylated (26 kDa), palmitoylated (35 kDa) and dimeric (70 kDa) cellular forms 41, 42 and an additional 18 kDa N terminal CSPα fragment. Actin, is a known exosome protein and is present in the conditioned media 43 . Exported CSPα is approximately 11 times higher in media from CSPα transfected CAD cells compared with vector transfected control cells, demonstrating that increasing cellular CSPα levels increases its secretion (Fig. 1B) . N terminal HA-or myc-and C terminal FLAG-tagged CSPα are all released from cells (Fig. 1C) , indicating that epitope tags do not influence CSPα's export, although the C terminal FLAG tag reduced immunodetection by the CSPα polyclonal antibody. In addition to CAD cells, transiently expressed FLAG-tagged-CSPα but not Flag-NECAP or Flag-DENND3 was released from HEK-293 cells (Fig. 1D ). Next we wanted to know if extracellular CSPα is a feature of transient expression, or if CSPα secretion is a more widely occurring event. To this end, we evaluated seven human CSF subjects who had no clinical evidence of CNS pathology for CSPα. All seven CSF samples evaluated were positive for CSPα, although the level of CSPα (in 50 μl) varied among subject samples ( Fig. 1E and data not shown). We also evaluated CSPα levels in conditioned media from human brain tumors of 11 distinct origins 44, 45 . Out of 11 brain tumor initiating cells examined, 9 were found to secrete CSPα. CSPα of a distinct molecular weight was identified in conditioned media from two separate human brain tumors (Fig. 1E , lower panel, lane 2 and data not shown). Together, these results confirm that export of CSPα occurs physiologically, pathologically as well as in cell culture.
CSPα is released in EV's. Since conditioned medium contains secreted proteins and different types of extracellular vesicles; including exosomes and microvesicles ( Fig. 2A) , we next established the nature of exported CSPα. CSPα is one of the most highly palmitoylated neural proteins 46 and we reasoned it could be secreted in exosomes that are derived from lipid rafts. Following the established ExoQuick precipitation technique (System Biosciences Inc), we isolated EV's enriched in exosomes from cell culture media that had been centrifuged to remove cell debris. Western blot analysis reveals that CSPα is present in EV's enriched for exosomes together with the exosomal marker flotillin 1 (Fig. 2B ). Actin and Hsc70/Hsp70, known exosomal proteins 43 , are also present in these CSPα-containing EV's ( Fig. 2C ). No large apoptotic bodies were present in the EV preparation. The observed EV size distribution in our preparations varied, with the most frequent size of EV's being 129+/−2.2 nm, however larger EV's were also present and the mean size of EV's was 175.3+/−3.5 nm ( Fig. 2D) .
We wanted to know if mutated CSPα is also secreted. Figure 2E shows that like WT CSPα, myc-tagged CSPα L115R , CSPα L116∆ and a CSPα HPD-AAA mutant that does not activate Hsp70 family members, are all released extracellularly. The pathogenesis of L115R and L116∆ CSPα mutants that cause ANCL 4-6 is not established, however CSPα L115R and CSPα L116∆ are predisposed to oligomerize and have reduced palmitoylation 42, 47, 48 . To examine whether these mutant CSPα's were exported or retained by neurons, myc-tagged CSPα L115R and CSPα L116∆ and loss-of-function CSPα HPD-AAA were transfected into CAD cells and EV's enriched for exosomes were analyzed 48 hrs later. Consistent with previous reports 42, 47, 48 , the 35 kDa palmitoylated CSPα species is significantly reduced in CSPα L115R , CSPα L116∆ expressing cells compared to cells expressing CSPα HPD-AAA and WT CSPα and expression of CSPα L115R and CSPα L116∆ results in formation of high molecular weight aggregates. These results demonstrate that like CSPα, CSPα mutants are present in EV's enriched for exosomes. Secretion of CSPα HPD-AAA indicates that export is independent of molecular interactions with Hsc70, whereas secretion of CSPα L115R and CSPα L116∆ suggests that export is independent of palmitoylation. Hsp90, an established exosomal protein 43 , is present in all EV's ( Fig. 2E ).
Co-secretion with CSPα.
Since the human mutations CSPα L115R and CSPα L116∆ lead to neurodegeneration but were secreted like WT CSPα, we wondered if WT and mutant CSPα differed in their time course of release. Figure 3 shows that CSPα L115R has a significantly slower time course than CSPα at 24 hrs (P < 0.05) and that CSPα, CSPα L115R and CSPα L116∆ release is abundant 48 hrs after transfection. The presence of FBS (5% exosome-free) did not alter CSPα secretion (Fig. 3B) . Surprisingly, endogenous DnaJB1, DnaJB11 and DnaJA1 were found to be co-secreted with CSPα ( Fig. 3B ). The presence of DnaJB1, DnaJB11 and DnaJA1 in EV's was confirmed by LC-MS/MS (data not shown). It is possible that these J domain containing chaperones are co-packaged as EV cargo, packaged into separate vesicles or alternatively, that they are independently secreted and subsequently associate with EV's extracellularly (i.e. attached to the EV surface). CSPα and DnaJB11 secretion does not change in the presence of serum while DnaJB1 and DnaJA1 release is reduced ( Fig. 3B ), highlighting differences among the secreted J proteins. Flotillin 1, Hsp90 and actin, known exosomal components, are shown. We then examined CSPα-containing EV's for presynaptic proteins that have been proposed to be CSPα targets 40, 42, [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] . As previously reported, SNAP25 expression is reduced 63, 64, 67 while BKα potassium channel levels are elevated 56 in synaptosomes from CSPα KO mice compared to WT mice. BKα potassium channel, SNAP25, dynamin, synaptotagmin and syntaxin are not abundant in EV's from CAD cells (Fig. 3C ). The putative CSPα client proteins G αs , clathrin heavy chain and Rab5 were observed to be exported in the absence or presence of CSPα or CSPα mutants.
CSPα promotes/chaperones export of disease-causing proteins.
We next asked if neuronal proteins associated with cellular toxicity were exported with CSPα in EV's. To this end we introduced the polyglutamine expanded protein 72Q huntingtin exon1 or superoxide dismutase-1 (SOD-1 G93A ) with WT or mutant CSPα. Trinucleotide (CAG) repeat expansions of the huntingtin gene causes Huntington's disease 68 . The length of the polyglutamine expansion is linked to the age of onset of Huntington's disease and the aggregation propensity of the huntingtin protein 68 . Aggregates of polyglutamine expanded huntingtin have been found within genetically normal tissue grafted into patients with progressing HD, revealing cell-to-cell transit of huntingtin aggregates in vivo 69 . Mutations in the gene encoding superoxide dismutase-1 (SOD-1), a copper-binding enzyme that functions as an antioxidant, lead to the motor neuron disease, amyotrophic lateral sclerosis (ALS) 70 . Misfolding, aggregation and cell-to-cell spread of mutant SOD-1 is mediated by both free floating aggregates as well as exosomes 34, 71 . Figure 4 shows that CSPα promotes cellular export of both polyglutamine expanded protein 72Q huntingtin exon1 and superoxide dismutase-1 (SOD-1 G93A ). CSPα L115R and CSPα L116∆ also effectively support the export of both 72Q huntingtin exon1 and SOD-1 G93A. Integrin-linked kinase is not exported from cells while G αs , clathrin heavy chain, actin and native SOD-1 (lower band) are exported in EV's in the absence and presence of CSPα and CSPα mutants. It is not known if export of these proteins is regulated by other DnaJ's. Although export of native huntingtin from CAD cells is not observed, both WT and mutant SOD-1 are exported and export is increased by CSPα. A small increase in the cellular release of actin, clathrin heavy chain and G αs is observed following transfection (vector), therefore 72Q huntingtin exon1 in EV's and SOD-1 G93A in media was quantified relative to actin ( Fig. 4E and F ).
Some differences between 72Q huntingtin exon1 and SOD-1 G93A secretion were observed. EV-exported-72Q huntingtin exon1 underwent degradation such that 2 prominent degradation products were found in EV's ( Fig. 4A ), however no SOD-1 G93A degradation was detected. Secreted 72Q huntingtin exon1 co-purified with EV's, while secreted SOD-1 G93A was both free floating and EV-associated, consistent with previous reports 33 . Finally, 72Q huntingtin exon1 release was 60% lower (P < 0.0001) in the presence of loss-of-function CSPα HPD-AAA compared to WT CSPα while SOD-1 G93A release, was 40% lower (P < 0.05) ( Fig. 4E and F) . Taken together, these results demonstrate that CSPα is exported and facilitates EV export of distinct toxic misfolded proteins. This export is dependent on the HPD motif of CSPα that is required for recruitment and activation of Hsc70 by CSPα. In contrast, the export of CSPα itself is not influenced by mutations in the HPD motif.
CSPα is secreted from brain. We next evaluated whether endogenous CSPα is released from mouse brain in addition to CAD cells. Brains were obtained at 23-25 days from CSPα knock out mice when they show partial paralysis and loss of neuromuscular control 7 . Mouse brains were sliced, washed in PBS, incubated in media for 2 hrs and EV's then isolated from the supernatant that had been filtered (30µm), centrifuged (2,000Xg) to remove debris and isolated by ExoQuick precipitation. Figure 5A shows that freshly removed murine brain tissue from WT mice exports EV's containing CSPα. As expected, no CSPα release is observed from CSPα knock out mice. CSPα is present in EV's prepared by either ultracentrifugation or ExoQuick methods. Given the smaller size of CSPα knock out relative to WT mice 7 , we evaluated release from both whole and hemi WT brains. We asked whether or not DnaJA1, DnaJB1, and DnaJB11 were found in EV's from mouse brain. Figure 5B shows that DnaJA1, DnaJB1, and DnaJB11 are indeed exported from both WT and CSPα knock out mouse brains. 1.5 µg of crude synaptosomes from WT mouse is shown in the right lane. No change in levels of DnaJA1, DnaJB1, DnaJB11 is found in synaptosomes from CSPα knock out mice ( Fig. 5C and D) . Taken together, these results indicate that CSPα and other J proteins are released from mammalian neurons and purify with EV's.
Resveratrol inhibits export of 72Q huntingtin exon1 . Finally we asked whether resveratrol treatment alters the CSPα promotion of disease-causing protein export. Resveratrol, a polyphenol with neurprotective, cardioprotective and anti-inflammatory properties, has been previously shown to ameliorate the reduced viability in C. elegans CSPα mutants 11 . Here we found that 50 µM resveratrol reduced 72Q huntingtin exon1 export by 70% ( Fig. 6) , indicating that the CSPα-mediated export of 72Q huntingtin exon1 is resveratrol-sensitive.
Discussion
In this study we directly demonstrate that the neuroprotective, synaptic chaperone CSPα is secreted via EV's and has a key role in the export of two misfolded, aggregation-prone proteins, polyglutamine expanded protein 72Q huntingtin exon1 and SOD-1 with a glycine to alanine amino acid substitution at position 93. Protection against the buildup of misfolded proteins that threaten synaptic function is in-line with CSPα's well-documented neuroprotective function 7, 10 . In addition to ANCL, the rare neurodegenerative disease caused by L115R and ∆L116 mutations 4-6 , CSPα dysfunction has been implicated in a number of other neurodegenerative disorders including Alzheimer's, Parkinson's and Huntington's disease however mechanistic links have not been determined 40, 42, 55, 67, 72, 73 . Our results clearly link CSPα to the motor neuron disorder ALS and polyglutamine expansion disorders like Huntington's disease and are congruent with a recent study by Fontaine and colleagues who reported that release of TDP-43, α-synuclein and microtubule-associated protein tau from HEK-293 cells is enhanced by CSPα 39 . Together, these studies suggest the CSPα pathway is a common mechanism that promotes/chaperones export of misfolded proteins, that said, the fate of the misfolded proteins that are exported by CSPα remains to be established. The CSPα-mediated export of 72Q huntingtin exon1 is resveratrol-sensitive. Effective clearance of the misfolded cargo by recipient cells would represent a novel quality control pathway, on the other hand, delivery of misfolded proteins to recipient cells and subsequent propagated protein misfolding is consistent with the pathogenic prion-like spreading reported for disease-causing proteins such as, beta-amyloid, tau, TDP-43, α-synuclein, huntingtin and SOD-1. This intersection-i.e. off-site disposal vs propagated misfolding of CSPα-exported protein-is significant, and further experimentation is required to better understand these processes.
The endogenous co-secretion of DnaJA1, DnaJB1, DnaJB11 with CSPα from both CAD cells and mouse brain tissue, indicates that cellular release of "J domain"-containing proteins is more common than previously appreciated. There are many possible roles for secreted "J domain"-containing chaperones, which likely target distinct client proteins including: regulation of the assembly of the EV proteins (eg. tetraspanins, clathrin), selection of EV cargo for export, ensuring delivery of conformationally intact and functional hydrophobic and cytosolic proteins between cells, increasing the folding capacity of recipient cells via cell-to-cell transit of molecular chaperones, selection of aggregate-prone toxic proteins for elimination by export and off-site degradation, regulation of trafficking of EV's to recipient cells and regulation of protein conformation in the extracellular space. Such processes could involve additional regulatory proteins. For example, a CSPα-interacting protein 74 , SGT (small glutamine-rich tetratricopeptide repeat containing protein) is reported to regulate whether or not misfolded proteins are targeted to late endosomes/MVBs 75 . These possible roles are based on the assumption that the secreted J proteins are indeed functional and don't themselves represent protein trash dedicated for export. It is clear that mutated J proteins can be exported, yet it remains to be determined if exported J proteins can promote Hsp70 ATPase activity. Several J domain-containing proteins have neuroprotective activity 15 and some, when mutated, cause neurodegenerative disease 76, 77 . For example, DnaJB6 and DnaJB2 are implicated in protection from Huntington's disease 78 and ALS 79 respectively. Some J domain-containing proteins have well characterized intracellular roles; for example Sec63 (DnaJC23), is involved in protein translocation across the ER membrane 80 and auxilin (DnaJC6), is important in uncoating clathrin coated vesicles during endocytosis 81, 82 . The fulminant neurodegeneration observed in CSPα knock-out models clearly indicates that other J proteins do not compensate in its absence.
There is currently great interest in EV's as vehicles for intercellular communication as well as shuttles for the spread of misfolded proteins that cause neurodegenerative disorders and tumor cell metastasis. We suggest that the maintenance of optimally functional synapses involves chaperone mediated-export of dysfunctional proteins. CSPα-mediated neuroprotection is activity-dependent 8, 83 and interestingly, release of exosomes from differentiated neurons has been reported to be regulated by synaptic activity 84 . An activity-dependent build-up of misfolded proteins may be common to the pathogenic cascade of distinct neurodegenerative diseases. Therefore, understanding export pathways is important, as it may allow for the development of therapeutics aimed at treating the progression of neurodegenerative disease.
Materials and Methods
Expression of chaperones, SOD-1 G93A and 72Q huntingtin exon1 in CAD cells. Maintenance of CAD (catecholaminergic derived CNS cells) was described before 56 . For expression in CAD cells, cDNAs encoding for CSPα and CSPα mutants were expressed in the plasmid myc-pCMV, HA-pCMV, pcDNA3.1-FLAG and pcDNA3.1-GFP. All mutations were confirmed by DNA sequence analysis. Constructs encoding Myc-tagged CSPα, Flag-tagged CSPα, HA-tagged Myc-tagged CSPα, Myc-tagged CSPα L115R , Myc-tagged CSPα ΔL116 , Myc-tagged CSPα HPD-AAA , GFP-72Q huntingtin exon1 and SOD-1 G93A -FLAG were transiently transfected with Lipofectamine 3000 (Invitrogen) in Opti-MEM ™ medium (Invitrogen). Media was changed to serum-free media 6 hrs post-transfection, or where indicated 5% exosome free FBS (Systems Biosciences). Where indicated, 50 µM resveratrol treatment (Sigma) started 6 hrs post-transfection.
CSF.
Cerbrospinal fluid (CSF) samples were collected by lumbar puncture under general anesthesia prior to microdiskectomy surgery. The subjects were symptomatic with degenerative disc disease refractory to non-surgical management for over 12 wks but lacked evidence of CNS pathology on history and physical examination by a neurosurgeon. All the samples were collected with informed consent for participation and publication in accordance with the guidelines and regulations of the University of Calgary institutional ethics/licensing committee.
Brain Tumor Initiating Cells. Surgical samples from patients with newly diagnosed or recurrent glioblastoma were obtained from the Tumor Tissue Bank within the Arnie Charbonneau Cancer Institute, transported to the BTIC Core Facility (Calgary, Alberta) and established as described previously 44, 45 . This study has Institutional review board approval under the "Brain Tumor and Related Tissue Bank protocol-V2" and approved by Foothills Hospital and the Conjoint Health Research Ethics Board and all methods were performed in accordance with the relevant guidelines and regulations. All established cell lines used were validated for identity by short tandem repeat analysis performed by Calgary Laboratory Services. All BTIC lines were grown in serum free-media supplemented with EGF (20 ng/ml; Peprotech, FGF2 (20 ng/ml; R&D Systems Inc, and heparin sulfate (2 mg/ml: R&D Systems). For the collection of conditioned media (CM) individual BTIC lines were plated at one million cells/ml, after 48 hrs media was collected and centrifuged to remove debris.
CAD cell Media and EV collection.
Media was collected 48 hrs after transfection unless otherwise indicated and spun at 1,500Xg for 10 min to remove cell debris. Media was concentrated 10Xs with YM 30,000, centricon filter (Millipore) at 5,000Xg for 30 min. Cells were lysed in: 40 mM Tris (pH7.4), 150 mM NaCl, 2 mM EDTA, 1 mM EGTA, 1% Triton X-100, 0.1% SDS with 1 mM Na 3 VO 4 , 0.5 mM PMSF and protease inhibitors (Sigma) at 4 °C for 1 hr. Lysates were centrifuged at 15000Xg for 5 min at 4° C and the supernatant (soluble fraction) was collected and stored at −70° C. Protein concentration of the soluble CAD cell lysate was determined using the Pierce BCA protein assay.
For isolation of EV's, media was harvested 48 hrs after transfection, spun at 2000Xg for 10 min to remove cell debris and the supernatant was combined 5:1 with exoquick precipitation solution (SBI), incubated overnight at 4 °C, centrifuged at 7,000Xg for 30 min, washed and resuspended in PBS.
Immunoblotting. Proteins were separated by SDS-PAGE and electrotransferred from polyacrylamide gels to nitrocellulose membrane (0.2 µm pore size). Membranes were blocked in tris-buffered saline (TBS) containing 0.1% Tween 20, 1% BSA and then incubated with primary antibody overnight at 4° C. The membranes were washed and incubated with horseradish peroxidase-coupled secondary antibody for ~2 hrs at room temperature. Bound antibodies (Supp Table 1 ) on the membranes were detected by incubation with Pierce chemiluminescent reagent and exposure to Cdigit, LiCor (Mandel). The chemiluminescent signals were quantified using image studio digits software (Mandel).
EV size determination. Nanosight finite track length analysis was used to determine the EV size distribution (System Biosciences).
Brain Slices. All mice were maintained in accordance with an animal protocol approved by the University of Calgary and the Guidelines for Lab Animal Safety. All methods were conducted in accordance with the relevant University of Calgary guidelines and regulations. We isolated EV's from the brains of 23-25 day old WT and littermate CSPα knock out mice by a procedure modified from ref. 85 . Mouse brains were removed, separated into hemi brains and the hemi brain sliced into four pieces and incubated for 2 hrs at 37 °C in 6 ml of hibernate A. Media was filtered through a 30 µm filter, centrifuged 2,000Xg for 10 min, the supernatant combined 5:1 with exoquick precipitation solution (SBI), incubated overnight at 4 °C, centrifuged at 7,000Xg for 30 min and washed and resuspended in PBS. For preparation of EV's by differential ultracentrifugation, media was filtered through a 30 µm filter and sequentially at centrifuged 2,000Xg for 10 min, and at 10,000Xg for 30 min at 4 °C to discard membranes and debris. The supernatant was then centrifuged at 100,000Xg for 2 hrs to pellet EV's enriched in exosomes.
Statistical Analysis.
All values are presented as the mean ± SEM and statistical significance was analyzed using a Student's t-test. Calculations were performed using GraphPad Prism 6 software.
